Global Bioenergies SA
EPA:ALGBE.PA
1.032 (EUR) • At close May 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.361 | 3.249 | 0.698 | 0.101 | 0.064 | 0.117 | 0.692 | 0.306 | 0.536 | 1.363 | 1.793 | 1.158 | 2.366 | 0.283 | 0 | 0 |
| Cost of Revenue
| 0.574 | 11.161 | 10.806 | 11.764 | 16.06 | 17.178 | 0.833 | 1.312 | 1.064 | 1.164 | 1.36 | 0.778 | 2.174 | 2.341 | 1.193 | 0.809 |
| Gross Profit
| -0.214 | -7.912 | -10.108 | -11.663 | -15.996 | -17.061 | -0.141 | -1.006 | -0.528 | 0.2 | 0.433 | 0.38 | 0.192 | -2.058 | -1.193 | -0.809 |
| Gross Profit Ratio
| -0.593 | -2.435 | -14.491 | -115.55 | -250.537 | -145.233 | -0.203 | -3.283 | -0.984 | 0.147 | 0.241 | 0.328 | 0.081 | -7.272 | 0 | 0 |
| Reseach & Development Expenses
| 0 | 0.346 | 0.343 | 0.68 | 0.929 | 1.234 | 1.386 | 1.819 | 0 | 0 | 1.805 | 1.411 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0.136 | 0.133 | 0.109 | 0.133 | 9.223 | 7.662 | 8.504 | 9.177 | 8.961 | 7.759 | 6.818 | 5.581 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0.06 | 0.148 | 0.305 | 1.287 | 0.029 | -7.417 | 5.132 | 4.979 | 4.556 | 4.07 | 2.374 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 0.196 | 2.91 | 2.564 | 3.503 | 0.218 | 0.245 | 13.636 | 14.156 | 13.517 | 11.829 | 9.192 | 5.581 | 0 | 0 | 0 | 0 |
| Other Expenses
| 5.684 | -1.29 | -1.175 | -0.925 | 0.085 | -0.09 | 0.301 | 0.707 | 3.569 | 0.868 | 0 | 1.468 | 0 | 1.891 | -0.004 | -0.003 |
| Operating Expenses
| 5.88 | -0.084 | 3.739 | 4.428 | 0.133 | 0.335 | 15.472 | 14.539 | 11.46 | 12.331 | 8.767 | 7.049 | 4.37 | 1.891 | 0.786 | 0.757 |
| Operating Income
| -6.093 | -9.711 | -13.848 | -16.091 | -16.129 | -17.395 | -15.676 | -15.634 | -11.924 | -12.013 | -8.316 | -6.67 | -4.159 | -3.907 | -1.975 | -1.568 |
| Operating Income Ratio
| -16.895 | -2.989 | -19.852 | -159.418 | -252.617 | -148.083 | -22.652 | -51.04 | -22.233 | -8.811 | -4.638 | -5.761 | -1.758 | -13.806 | 0 | 0 |
| Total Other Income Expenses Net
| -1.019 | -0.132 | -0.242 | -0.133 | -0.356 | -0.125 | -0.507 | -0.619 | -0.579 | -0.367 | 0.184 | 0.046 | 0.109 | 0.037 | -0.017 | 0 |
| Income Before Tax
| -7.112 | -9.843 | -13.434 | -13.481 | -13.412 | -14.149 | -16.183 | -16.252 | -12.503 | -12.38 | -8.132 | -6.545 | -4.069 | -3.912 | -1.992 | -1.568 |
| Income Before Tax Ratio
| -19.72 | -3.029 | -19.259 | -133.557 | -210.073 | -120.443 | -23.384 | -53.06 | -23.313 | -9.08 | -4.535 | -5.654 | -1.72 | -13.823 | 0 | 0 |
| Income Tax Expense
| -1.251 | -1.187 | -1.447 | -1.708 | -2.264 | -1.407 | 2.546 | 1.999 | 1.896 | 1.985 | 1.876 | -1.413 | -0.885 | -0.407 | -0.41 | -0.269 |
| Net Income
| -5.861 | -8.656 | -11.986 | -11.773 | -11.148 | -12.741 | -13.637 | -14.253 | -10.607 | -10.395 | -6.256 | -5.132 | 2.683 | -3.505 | -1.582 | -1.299 |
| Net Income Ratio
| -16.251 | -2.664 | -17.184 | -116.64 | -174.61 | -108.463 | -19.705 | -46.533 | -19.778 | -7.624 | -3.489 | -4.433 | 1.134 | -12.385 | 0 | 0 |
| EPS
| -0.32 | -0.48 | -0.79 | -0.78 | -1.08 | -1.44 | -2.69 | -3.18 | -3.17 | -3.68 | -2.25 | -1.86 | 0 | -2.08 | -0.99 | -27.03 |
| EPS Diluted
| -0.32 | -0.48 | -0.79 | -0.78 | -1.08 | -1.44 | -2.69 | -3.18 | -3.17 | -3.68 | -2.25 | -1.83 | 0 | -2.08 | -0.99 | -27.03 |
| EBITDA
| -4.314 | -8.189 | -12.799 | -12.205 | -9.895 | -10.306 | -11.971 | -12.553 | -10.729 | -11.024 | -8.759 | -6.284 | -4 | -3.862 | -1.937 | -1.548 |
| EBITDA Ratio
| -11.96 | -2.52 | -18.349 | -120.922 | -154.978 | -87.729 | -17.298 | -40.983 | -20.005 | -8.085 | -4.885 | -5.429 | -1.691 | -13.647 | 0 | 0 |